Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

Condition:   Bioequivalence Intervention:   Drug: Orlistat 60mg Cap Sponsor:   Shandong New Time Pharmaceutical Co., LTD Completed

Source: ClinicalTrials.gov - October 13, 2021 Category: Research Source Type: clinical trials